Effect of a CCK-1R Agonist on Food Intake in Humans

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Bulimia
Interventions
DRUG

GSKI181771X (CCK-1R agonist)

Drug one trial vs placebo

BEHAVIORAL

Instructions to binge eat

Subjects will be instructed to binge eat and will also be given either drug or placebo

BEHAVIORAL

Instructions to eat normally

Subjects will be instructed to eat normally and will also be given either drug or placebo

DRUG

Placebo

Drug one trial vs placebo

Trial Locations (1)

10025

St. Luke's/Roosevelt Hospital, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER